This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at up to $999,999,999, tasks Amerisourcebergen with providing a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide over the period of performance ending November 30, 2026.
Key products and services being delivered under this IDC include specialty medications, brand-name and generic drugs, vaccines, medical supplies, and equipment across various therapeutic areas. Amerisourcebergen leverages its extensive supply chain and distribution capabilities to efficiently procure and deliver these critical care materials, such as syringes, vials, and test kits, to military treatment facilities, veterans' hospitals, and other federal healthcare providers. This IDC serves as a primary vehicle for the DLA to obtain essential pharmaceutical and medical commodities required to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 1/1/25, 9:06 AM